1. Protein Mannosylation as a Diagnostic and Prognostic Biomarker of Lupus Nephritis: An Unusual Glycan Neoepitope in Systemic Lupus Erythematosus
- Author
-
Carlos Vasconcelos, Lèlita Santos, Hans Dalebout, Manfred Wuhrer, Ana Campar, Salomé S. Pinho, Ramon Vizcaíno, Inês Alves, Manuel M. Vicente, Franck Fieschi, Roberto Carlos Delmas da Silva, Beatriz Santos-Pereira, Sofia Santos, Stephanie Holst-Bernal, Fanny Boyaval, Bram Heijs, António Marinho, Michel Thépaut, Sabine Strahl, Institute for Research and Innovation in Health (i3S), Universidade do Porto = University of Porto, Center for Proteomics and Metabolomics [Leiden] (CPM), Leiden University Medical Center (LUMC), Universiteit Leiden-Universiteit Leiden, Porto University Hospital Center, Unidade de Imunologia Clínica, Centro Hospitalar do Porto, Portugal, Institut de biologie structurale (IBS - UMR 5075), Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Grenoble Alpes (UGA), University of Heidelberg, Medical Faculty, Centro Hospitalar Universitário de São João [Porto], Institute of Biomedical Sciences Abel Salazar - ICBAS [Porto, Portugal], Coimbra University Centre Hospital, ANR-17-EURE-0003,CBH-EUR-GS,CBH-EUR-GS(2017), and Universidade do Porto
- Subjects
Adult ,Male ,Glycan ,Glycosylation ,Immunology ,Lupus nephritis ,Kidney ,Glycomics ,Pathogenesis ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Rheumatology ,Polysaccharides ,Humans ,Lupus Erythematosus, Systemic ,Immunology and Allergy ,Medicine ,Aged ,030304 developmental biology ,0303 health sciences ,[SDV.BBM.BS]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Structural Biology [q-bio.BM] ,biology ,business.industry ,Middle Aged ,Prognosis ,medicine.disease ,Lupus Nephritis ,3. Good health ,carbohydrates (lipids) ,chemistry ,030220 oncology & carcinogenesis ,Mannosylation ,Disease Progression ,biology.protein ,Cancer research ,Female ,Protein mannosylation ,business ,Biomarkers ,Kidney disease - Abstract
Objectives Changes in protein glycosylation are a hallmark of immune-mediated diseases. Glycans are master regulators of the inflammatory response being important molecules for the discrimination between "self"/"non-self". We here explored whether lupus nephritis (LN) exhibit an altered cellular glycosylation aiming to identify a unique glycosignature that characterizes LN pathogenesis. Methods A comprehensive tissue glycomics characterization was performed in a cohort of human biopsy-proven LN clinical samples from SLE patients. A combination of advanced tissue mass spectrometry imaging (MSI); in situ glyco-characterization and ex vivo glycophenotyping of human kidney biopsies were performed to structurally map the N-glycans repertoire in LN samples. Results LN revealed a unique glycan signature characterized by an increased abundance and spatial distribution of unusual mannose-enriched glycans that are typically found in lower microorganisms; this glycosignature was specific of LN as it was not observed in other kidney diseases. Exposure of mannosylated glycans in LN was found to occur at the cell surface of kidney cells promoting an increased recognition by specific glycans-recognizing receptors, expressed by immune cells. This abnormal glyco-signature of LN was demonstrated to be due to a deficient complex N-glycosylation and a proficient O-mannosylation pathway. Moreover, levels of mannosylation detected in kidney biopsies from LN patients at diagnosis were demonstrated to predict the development of chronic kidney disease (CKD) with 93% of specificity. Conclusions Cellular mannosylation is a marker of LN, predicting the development of CKD, and thus constituting a potential glycobiomarker to be included in the diagnostic and prognostic algorithm of LN.
- Published
- 2021
- Full Text
- View/download PDF